Spots Global Cancer Trial Database for lovastatin
Every month we try and update this database with for lovastatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma | NCT00963664 | Melanoma Malignant Melan... | lovastatin interferon alfa... | 18 Years - | NeoPlas Innovation | |
| Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients | NCT02862470 | Thyroid Cancer | 20 Years - | National Taiwan University Hospital | ||
| Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury | NCT00580970 | Prostate Cancer | lovastatin | 18 Years - | Virginia Commonwealth University | |
| Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury | NCT00580970 | Prostate Cancer | lovastatin | 18 Years - | Virginia Commonwealth University | |
| Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) | NCT00352599 | Neurofibromatos... | Lovastatin Lovastatin placebo pill | 10 Years - 50 Years | University of California, Los Angeles | |
| A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer | NCT00584012 | Any Cancer Breast Cancer | Lovastatin Docetaxel | 19 Years - 90 Years | University of Iowa | |
| Interventions for Reading Disabilities in NF1 | NCT02964884 | Neurofibromatos... Learning Disabi... Reading Disabil... NF1 | Lovastatin reading tutorin... Placebo Oral Ta... Other Academic ... | 8 Years - 20 Years | Vanderbilt University | |
| Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention | NCT00285857 | Breast Cancer | Lovastatin | 18 Years - 65 Years | Stanford University | |
| A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer | NCT00585052 | Ovarian Cancer | Paclitaxel Lovastatin | 18 Years - 99 Years | University of Iowa | |
| Lovastatin in Treating Patients At High Risk of Melanoma | NCT00462280 | Precancerous Co... Stage 0 Melanom... Stage I Melanom... Stage II Melano... | lovastatin placebo biopsy laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Lovastatin in Treating Patients At High Risk of Melanoma | NCT00462280 | Precancerous Co... Stage 0 Melanom... Stage I Melanom... Stage II Melano... | lovastatin placebo biopsy laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Pre-Prostatectomy Lovastatin on Prostate Cancer | NCT01478828 | Prostate Cancer | Lovastatin | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma | NCT00963664 | Melanoma Malignant Melan... | lovastatin interferon alfa... | 18 Years - | NeoPlas Innovation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
